ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Evonik Industries will expand production of poly-lactic-glycolic acid (PLGA), used to make biodegradable polymers, at its facilities in Birmingham, Ala., and Darmstadt, Germany. The firm will open a PLGA lab for medical device customers in Darmstadt by year-end. A lab for polymer contract research projects is planned for Birmingham. Evonik will also increase capacity for its Rohacell brand of rigid polymethacrylimide foam in Darmstadt by 20% in the second half of 2017. The firm expects sales to continue to rise at a double-digit rate.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter